Priligy (dapoxetine) is a new drug that helps men with premature ejaculation. Its makers applied for approval in the US and were rejected. Recently, though, it's achieved approval in some European countries. It looks like they're going to have another go-around at trying to get approved in the US:
A DRUG company will pursue US approval for the world's first pill to treat premature ejaculation after tests on 6000 men showed it more than tripled the time before they reached climax.
Johnson & Johnson also seeks to sell the pill in Australia, Canada, Mexico, Turkey and six other countries.
The story of Priligy is an interesting one. The drug was initially developed as an antidepressant, but it didn't last long enough in the user's system to be effective. A common side effect of antidepressants is delayed ejaculation. So the drug was repurposed to help with premature ejaculation.
It should be available shortly in some European countries; we'll have to see how men react and how useful they find it. Right now our arsenal is pretty limited; Viagra, Cialis, and Levitra pretty much do the same thing with a few variations. Having a drug just to target premature ejaculation could help a lot of men, especially younger ones who don't have difficulty achieveing erecton.